Arcus Biosciences (RCUS) EPS (Basic): 2017-2025
Historic EPS (Basic) for Arcus Biosciences (RCUS) over the last 7 years, with Sep 2025 value amounting to -$1.27.
- Arcus Biosciences' EPS (Basic) fell 27.00% to -$1.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.44, marking a year-over-year decrease of 40.95%. This contributed to the annual value of -$3.14 for FY2024, which is 24.34% up from last year.
- Per Arcus Biosciences' latest filing, its EPS (Basic) stood at -$1.27 for Q3 2025, which was down 11.40% from -$1.14 recorded in Q1 2025.
- In the past 5 years, Arcus Biosciences' EPS (Basic) ranged from a high of $4.04 in Q4 2021 and a low of -$1.27 during Q3 2025.
- In the last 3 years, Arcus Biosciences' EPS (Basic) had a median value of -$1.04 in 2023 and averaged -$0.97.
- The largest annual percentage gain for Arcus Biosciences' EPS (Basic) in the last 5 years was 564.37% (2021), contrasted with its biggest fall of 3,800.00% (2021).
- Over the past 5 years, Arcus Biosciences' EPS (Basic) (Quarterly) stood at $4.04 in 2021, then tumbled by 123.02% to -$0.93 in 2022, then declined by 16.13% to -$1.08 in 2023, then increased by 4.63% to -$1.03 in 2024, then fell by 27.00% to -$1.27 in 2025.
- Its EPS (Basic) was -$1.27 in Q3 2025, compared to -$1.14 in Q1 2025 and -$1.03 in Q4 2024.